Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors

被引:45
|
作者
Eggener, Scott E.
Carver, Brett S.
Loeb, Stacy
Kondagunta, G. Varuni
Bosl, George J.
Sheinfeld, Joel
机构
[1] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Urol Serv, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Oncol Serv, Div Solid Tumor Oncol, New York, NY 10021 USA
[3] Georgetown Univ, Sch Med, Dept Urol, Washington, DC 20057 USA
关键词
retroperitoneal lymph node dissection; salvage therapy; chemotherapy; testicular neoplasms; metastatic;
D O I
10.1002/cncr.22440
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Postchemotherapy surgery is an essential component in the management of patients with metastatic germ cell tumors (GCT). The authors assessed their institutional experience of retroperitoneal lymph node dissection (RPLND) after multiple chemotherapy regimens for advanced GCT. METHODS. By analyzing the institutional prospective surgical database from 1989 to 2004, 71 patients were identified who underwent RPLND after multiple chemotherapy regimens. Clinicopathologic and treatment trends were characterized, and predictors of disease-specific survival (DSS) were evaluated. RESULTS. The histologic findings at RPLND were fibrosis in 36 men (51%), GCT in 20 men (28%), and teratoma in 15 men (21%). Patients who underwent RPLND from 1989 to 1998 (n = 47), compared with patients who under-went RPLND from 1999 to 2004 (n = 24) were more likely to have GCT (36% vs 13%; P = .04). Patients who received taxane-containing chemotherapy regimens as salvage therapy had lower rates of GCT at RPLND (14% vs 42%; P = .01), higher rates of fibrosis (63% vs 39%; P = .04), and similar rates of teratoma (31% vs 33%; P = .9). The 5- and 10-year DSS rates were 74% (95% confidence interval [95% CI], 62-86%) and 70% (95% CI, 56-84%), respectively. Five-year DSS based on worst histology of RPLND and extraretroperitoneal specimens was 87% (95% CI, 75-99%) for fibrosis, 87% for teratoma (95% CI, 63-100%), and 47% for GCT (95% CI, 23-71%; P = .004). On multivariable analysis, retroperitoneal mass >= 5 cm and GCT were predictors of worse DSS (P = .03 and P = .005, respectively). CONCLUSIONS. Taxane-based salvage chemotherapeutic regimens appear to have decreased the rate of GCT at RPLND. The current data support RPLND in select patients after salvage chemotherapy, because a considerable proportion has teratoma or GCT, and the 10-year DSS rate after resection is 70%.
引用
收藏
页码:528 / 535
页数:8
相关论文
共 50 条
  • [41] Post chemotherapy robotic retroperitoneal lymph node dissection for metastatic testicular cancer
    McClintock, George
    Goolam, Ahmed
    Perera, Don
    Downey, Ryan
    Leslie, Scott
    Grimison, A. Peter
    Woo, Henry
    Ferguson, Peter
    Ahmadi, Nariman
    BJU INTERNATIONAL, 2022, 129 : 148 - 149
  • [42] LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION AFTER CHEMOTHERAPY FOR TESTICULAR CANCER
    Nishimura, Kazuo
    Ueda, Norichika
    Yamamoto, Yoshiyuki
    Takeda, Ken
    Nakata, Wataru
    Arai, Yasuyuki
    Nakayama, Masashi
    Kakimoto, Kanichi
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A206 - A206
  • [44] EXTRAPERITONEAL LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR EARLY STAGE TESTICULAR NONSEMINOMATOUS GERM CELL TUMORS
    Yin, Changjun
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A163 - A164
  • [45] Re: Pathological Findings after Primary Chemotherapy in Patients Undergoing Simultaneous Orchidectomy and Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumours Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2013, 190 (06): : 2096 - 2096
  • [46] Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors
    Nayan, Madhur
    Jewett, Michael A. S.
    Sweet, Joan
    Anson-Cartwright, Lynn
    Bedard, Philippe L.
    Moore, Malcolm
    Chung, Peter
    Warde, Padraig
    Hamilton, Robert J.
    JOURNAL OF UROLOGY, 2015, 194 (02): : 386 - 391
  • [47] Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor
    Murphy, Alana M.
    McKiernan, James M.
    WORLD JOURNAL OF UROLOGY, 2009, 27 (04) : 501 - 506
  • [48] Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor
    Alana M. Murphy
    James M. McKiernan
    World Journal of Urology, 2009, 27 : 501 - 506
  • [49] RADICAL RETROPERITONEAL NODE DISSECTION AFTER CHEMOTHERAPY FOR TESTICULAR-TUMORS
    WILLIAMS, SN
    JENKINS, BJ
    BAITHUN, SI
    OLIVER, RTD
    BLANDY, JP
    BRITISH JOURNAL OF UROLOGY, 1989, 63 (06): : 641 - 643
  • [50] Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy
    Rassweiler, JJ
    Henkel, TO
    Stock, C
    Seemann, O
    Frede, T
    Alken, P
    LYMPHOLOGY, 1996, 29 (01) : 36 - 44